Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. (Q54459170)

30 May 2018

title

Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. (English)

1 reference

30 May 2018

author name string

Jeng-Wei Lu

1 reference

30 May 2018

Yueh-Min Lin

1 reference

30 May 2018

Jan-Gowth Chang

1 reference

30 May 2018

Kun-Tu Yeh

1 reference

30 May 2018

Rong-Ming Chen

1 reference

30 May 2018

Jeffrey J P Tsai

1 reference

30 May 2018

Wei-Wen Su

1 reference

30 May 2018

Rouh-Mei Hu

1 reference

30 May 2018

publication date

5 January 2013

1 reference

30 May 2018

published in

Medical Oncology

1 reference

30 May 2018

volume

1 reference

30 May 2018

issue

1 reference

30 May 2018

page(s)

379

1 reference

30 May 2018

G1 events and regulation of cell proliferation

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

The retinoblastoma protein pathway and the restriction point

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cell cycle, CDKs and cancer: a changing paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cycling to cancer with cyclin D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Elevated expression of CDK4 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Overexpression of cdk4/cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Requirement for CDK4 kinase function in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

21 January 2018

Cyclin D and oncogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Nuclear cyclin D1: an oncogenic driver in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Hepatocellular carcinoma: an epidemiologic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Early HCC: diagnosis and molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Abnormal expression of period 1 (PER1) in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Gene expression patterns in human liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Role of cyclin D1 amplification and expression in vulvar carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Expression of Cyclin D1 Is Associated with β-Catenin Expression and Correlates with Good Prognosis in Colorectal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1, Id1 and EMT in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1 expression is regulated by the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence

1 reference

12 December 2020

Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation

1 reference

12 December 2020

Cyclin D1 predicts the prognosis of advanced serous ovarian cancer

1 reference

12 December 2020

Molecular genetics of hepatocellular neoplasia.

1 reference

12 December 2020

Cyclin D1 amplification in tongue and cheek squamous cell carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma

1 reference

12 December 2020

Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis

1 reference

12 December 2020

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines

1 reference

12 December 2020

Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Is Cyclin D1-CDK4 kinase a bona fide cancer target?

1 reference

12 December 2020

Immunohistochemistry of cyclin D1 in human breast cancer

1 reference

12 December 2020

Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis

1 reference

12 December 2020

Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma

1 reference

12 December 2020

Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines

1 reference

12 December 2020

Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours

1 reference

12 December 2020

Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

Abnormal expression of JUNB gene in hepatocellular carcinoma

1 reference

12 December 2020

Cyclin D1 overexpression in hepatocellular carcinoma

1 reference

12 December 2020

Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas

1 reference

12 December 2020

Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.

1 reference

12 December 2020

p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas

1 reference

12 December 2020

Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.

1 reference

12 December 2020

A role for Cdk4 in angiogenesis.

1 reference

12 December 2020

10.1007/S12032-012-0379-5

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018